BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Regulus Therapeutics, Inc. (RGLS) Receives Orphan Medicinal Product Designation From The European Commission (EC) For RG-012, A Microrna Therapeutic In Development For The Treatment Of Alport Syndrome 3/25/2015 6:43:15 AM
Regulus Therapeutics, Inc. (RGLS) To Present At Cowen and Company 35th Annual Healthcare Conference 2/27/2015 9:42:49 AM
Regulus Therapeutics, Inc. (RGLS) To Present At 2015 RBC Capital Markets' Healthcare Conference 2/20/2015 8:42:34 AM
Regulus Therapeutics, Inc. (RGLS) Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights 2/19/2015 11:46:04 AM
Regulus Therapeutics, Inc. (RGLS) Announces Timing For Fourth Quarter And Year-End 2014 Financial Results Webcast And Conference Call 2/13/2015 6:56:47 AM
Regulus Therapeutics, Inc. (RGLS) To Ring The Nasdaq Stock Market Closing Bell 2/9/2015 9:47:10 AM
Regulus Therapeutics, Inc. (RGLS) Release: All HCV Patients Treated with a Single SC Administration Of 4 Mg/Kg Of RG-101 Responded With Mean Viral Load Reduction Of 4.8 Log10 At Day 29 And 9/14 Patients Are Below The Limit Of Quantification At Day 57 2/9/2015 8:58:18 AM
Regulus Therapeutics, Inc. (RGLS) To Present At Two Upcoming Investor Conferences 2/3/2015 11:46:56 AM
Regulus Therapeutics, Inc. (RGLS) Earns Milestone Payment From Biogen Idec (BIIB) Related To The Identification Of Potential Microrna Biomarkers In Multiple Sclerosis 2/2/2015 10:03:08 AM
Regulus Therapeutics, Inc. (RGLS) Announces Key Goals Under Its 'Clinical Map Initiative' For 2015 1/8/2015 9:36:14 AM
12345678910...